Ethnic differences in intrahepatic lipid and its association with hepatic insulin sensitivity and insulin clearance between men of black and white ethnicity with early type 2 diabetes.


Journal

Diabetes, obesity & metabolism
ISSN: 1463-1326
Titre abrégé: Diabetes Obes Metab
Pays: England
ID NLM: 100883645

Informations de publication

Date de publication:
09 2019
Historique:
received: 03 03 2019
revised: 03 05 2019
accepted: 07 05 2019
pubmed: 11 5 2019
medline: 14 7 2020
entrez: 11 5 2019
Statut: ppublish

Résumé

Intrahepatic lipid (IHL) is linked with reduced hepatic insulin sensitivity and insulin clearance. Despite their high risk for type 2 diabetes (T2D), there have been limited investigations of these relationships in black populations. We investigated these relationships in 18 white European (WE) and 18 black West African (BWA) men with T2D <5 years. They underwent magnetic resonance imaging to quantify IHL, a hyperinsulinemic euglycaemic clamp with [6,6

Identifiants

pubmed: 31074174
doi: 10.1111/dom.13771
doi:

Substances chimiques

Insulin 0
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2163-2168

Informations de copyright

© 2019 John Wiley & Sons Ltd.

Auteurs

Olah Hakim (O)

Department of Diabetes, School of Life Course Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.

Oluwatoyosi Bello (O)

Department of Diabetes, School of Life Course Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.

Riccardo C Bonadonna (RC)

Department of Medicine & Surgery, University of Parma and Azienda Ospedaliera, Universitaria di Parma, Parma, Italy.

Cynthia Mohandas (C)

Department of Diabetes, School of Life Course Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.

Fariba Shojaee-Moradie (F)

Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.

Nicola Jackson (N)

Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.

Linda Boselli (L)

Division of Endocrinology and Metabolic Disease, University of Verona School of Medicine, Verona, Italy.

Brandon Whitcher (B)

Research Centre for Optimal Health, School of Life Sciences, University of Westminster, London, UK.

Haris Shuaib (H)

Department of Medical Physics, Guy's & St Thomas' NHS Foundation Trust, London, UK.
Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Kurt George M M Alberti (KGMM)

Department of Diabetes, School of Life Course Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.

Janet L Peacock (JL)

School of Population Health and Environmental Sciences, King's College London, London, UK.

Anne Margot Umpleby (AM)

Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.

Geoffrey Charles-Edwards (G)

Department of Medical Physics, Guy's & St Thomas' NHS Foundation Trust, London, UK.
School of Biomedical Engineering & Imaging Sciences, King's College London, London, UK.

Stephanie A Amiel (SA)

Department of Diabetes, School of Life Course Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.

Louise M Goff (LM)

Department of Diabetes, School of Life Course Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH